Investigation of center-specific saphenous vein utilization rates in femoral popliteal artery bypass and associated impact of conduit on outcomes.


Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
12 2023
Historique:
received: 13 07 2023
revised: 14 08 2023
accepted: 19 08 2023
medline: 21 11 2023
pubmed: 31 8 2023
entrez: 30 8 2023
Statut: ppublish

Résumé

The purpose of this study is to investigate variation in great saphenous vein (GSV) use among the various centers participating in the Vascular Quality Initiative infrainguinal bypass modules. Further, differences in outcomes in femoral-popliteal artery bypass with single segment GSV conduit vs prosthetic conduit will be documented. Center GSV use rate impact on outcomes will be investigated. Primary exclusions were patients undergoing redo bypass, urgent or emergent bypass, and those in whom prosthetic graft was used while having undergone prior coronary artery bypass grafting. The distribution of GSV use across the 260 centers participating in Vascular Quality Initiative infrainguinal bypass module was placed into histogram and variance in mean GSV use evaluated with analysis of variance analysis. Centers that used GSV in >50% of bypasses were categorized as high use centers and centers that used the GSV in <30% of cases were categorized as low use centers. Baseline differences in patient characteristics and comorbidities in those undergoing bypass with GSV vs prosthetic conduit were analyzed with χ Among centers with >50 patients meeting inclusion criteria for this study, GSV use ranged from 15% to 93% (analysis of variance P < .001). When considering all centers irrespective of number of patients, the range was 0% to 100%. On Kaplan-Meier analysis, GSV conduit use was associated with improved freedom from loss of primary or primary assisted patency, improved freedom from major amputation after index hospitalization, improved freedom from graft infection after the index hospitalization, and improved freedom from mortality in long-term follow-up (log-rank P < .001 for all four outcomes). Both low use center (hazard ratio, 1.35; P < .001) and prosthetic graft use (hazard ratio, 1.24; P < .001) achieved multivariable significance as risks for mortality in long-term follow-up. Other variables with a multivariable mortality association are presented in the manuscript. Low use center and prosthetic bypass were significant univariable but not multivariable risks for major amputation after index hospitalization. There is remarkably wide variation in GSV use for femoral popliteal artery bypass among various medical centers. GSV use is associated with enhanced long-term survival as well as freedom from loss of bypass patency and graft infection. The data herein indicate institutional patterns of prosthetic conduit choice, which has the potential to be altered to enhance outcomes.

Identifiants

pubmed: 37648090
pii: S0741-5214(23)01937-7
doi: 10.1016/j.jvs.2023.08.123
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1497-1512.e3

Subventions

Organisme : NHLBI NIH HHS
ID : T35 HL120835
Pays : United States

Informations de copyright

Copyright © 2023 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosures None.

Auteurs

Michael Parker (M)

Loyola University Chicago, Stritch School of Medicine, Loyola University Health System, Division of Vascular Surgery and Endovascular Therapy, Chicago, IL.

Ashley Penton (A)

Loyola University Chicago, Stritch School of Medicine, Loyola University Health System, Division of Vascular Surgery and Endovascular Therapy, Chicago, IL.

Shannon McDonnell (S)

Loyola University Chicago, Stritch School of Medicine, Loyola University Health System, Division of Vascular Surgery and Endovascular Therapy, Chicago, IL.

Grant Kolde (G)

Loyola University Chicago, Stritch School of Medicine, Loyola University Health System, Division of Vascular Surgery and Endovascular Therapy, Chicago, IL.

Trissa Babrowski (T)

University of Chicago Medical Center, Pritzker School of Medicine, Section of Vascular Surgery and Endovascular Therapy, Chicago, IL.

Matthew Blecha (M)

Loyola University Chicago, Stritch School of Medicine, Loyola University Health System, Division of Vascular Surgery and Endovascular Therapy, Chicago, IL. Electronic address: matthew.blecha@lumc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH